PYC Therapeutics Limited

ASX (AUD): PYC Therapeutics Limited (PYC)

Last Price

1.87

Today's Change

+1.68 (886.84%)

Day's Change

1.85 - 1.90

Trading Volume

9,816

Overview

Market Cap

838 Million

Shares Outstanding

447 Million

Avg Volume

442,634

Avg Price (50 Days)

1.82

Avg Price (200 Days)

1.23

PE Ratio

-18.75

EPS

-0.10

Earnings Announcement

27-Feb-2025

Previous Close

0.19

Open

1.90

Day's Range

1.85 - 1.9

Year Range

0.721411 - 2.1

Trading Volume

9,816

Price Change Highlight

1 Day Change

886.84%

5 Day Change

-1.32%

1 Month Change

4.17%

3 Month Change

70.45%

6 Month Change

56.25%

Ytd Change

87.50%

1 Year Change

128.66%

3 Year Change

29.31%

5 Year Change

204.67%

10 Year Change

1321.75%

Max Change

-11.97%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment